Arnold M. Baskies, Director at Baudax Bio, Inc. (BXRX), bought 10,000 shares at $0.82 ($8K) on 2021-05-11, disclosed to the SEC on 2021-05-13.
Open-market purchase of $8k BXRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ANIX | BUY | 2025-07-21 | $17K | — | Filing → |
| ANIX | BUY | 2025-01-29 | $14K | — | Filing → |
| ANIX | BUY | 2024-07-26 | $15K | — | Filing → |